Citigroup’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.5M | Buy |
42,346
+4,183
| +11% | +$148K | ﹤0.01% | 2262 |
|
2025
Q1 | $1.29M | Sell |
38,163
-7,385
| -16% | -$251K | ﹤0.01% | 2388 |
|
2024
Q4 | $1.48M | Buy |
45,548
+3,550
| +8% | +$116K | ﹤0.01% | 2323 |
|
2024
Q3 | $2.05M | Sell |
41,998
-1,482
| -3% | -$72.2K | ﹤0.01% | 2022 |
|
2024
Q2 | $1.93M | Buy |
43,480
+3,776
| +10% | +$167K | ﹤0.01% | 1787 |
|
2024
Q1 | $2.23M | Sell |
39,704
-30,795
| -44% | -$1.73M | ﹤0.01% | 1769 |
|
2023
Q4 | $4.24M | Sell |
70,499
-8,895
| -11% | -$535K | ﹤0.01% | 1215 |
|
2023
Q3 | $5.33M | Buy |
79,394
+4,427
| +6% | +$297K | ﹤0.01% | 1007 |
|
2023
Q2 | $5.17M | Sell |
74,967
-8,103
| -10% | -$559K | ﹤0.01% | 1074 |
|
2023
Q1 | $4.01M | Buy |
83,070
+7,265
| +10% | +$350K | ﹤0.01% | 1211 |
|
2022
Q4 | $3.78M | Buy |
75,805
+5,491
| +8% | +$274K | ﹤0.01% | 1185 |
|
2022
Q3 | $2.87M | Sell |
70,314
-44,082
| -39% | -$1.8M | ﹤0.01% | 1392 |
|
2022
Q2 | $6.29M | Buy |
114,396
+53,094
| +87% | +$2.92M | ﹤0.01% | 1015 |
|
2022
Q1 | $2.23M | Buy |
61,302
+11,188
| +22% | +$407K | ﹤0.01% | 1708 |
|
2021
Q4 | $2.34M | Buy |
50,114
+34,543
| +222% | +$1.61M | ﹤0.01% | 1852 |
|
2021
Q3 | $788K | Buy |
15,571
+7,828
| +101% | +$396K | ﹤0.01% | 2570 |
|
2021
Q2 | $318K | Buy |
7,743
+7,286
| +1,594% | +$299K | ﹤0.01% | 3332 |
|
2021
Q1 | $13K | Sell |
457
-183
| -29% | -$5.21K | ﹤0.01% | 4821 |
|
2020
Q4 | $18K | Buy |
+640
| New | +$18K | ﹤0.01% | 4683 |
|